Skip to main content
. 2023 Jul 17;10:1171703. doi: 10.3389/fcvm.2023.1171703

Table 3.

Unadjusted and adjusted logistic regression analyses for rapid progression in patients with mild to moderate aortic stenosis.

Univariable Multivariable
OR (95% CI) p value OR (95% CI) p value
Follow-up durations, year 0.57 (0.46–0.70) < 0.001* 0.59 (0.45–0.76) < 0.001
Age, year 1.02 (0.99–1.06) 0.175*
Male gender 2.02 (1.18–3.46) 0.010*
Body mass index, kg/m2 1.03 (0.96–1.10) 0.488
Smoking ever 1.02 (0.48–2.17) 0.967
Hypertension 0.59 (0.31–1.11) 0.100*
Diabetes 1.00 (0.57–1.74) 0.991
Dyslipidemia 0.98 (0.56–1.72) 0.951
Coronary artery disease 0.86 (0.43–1.72) 0.671
Creatinine, mg/dl 0.81 (0.56–1.16) 0.254
CRP, mg/dl 0.97 (0.90–1.04) 0.315
LDL-C, mg/dl 1.00 (0.99–1.01) 0.262
LVEDD, mm 1.03 (0.99–1.08) 0.141*
LVESD, mm 1.07 (1.03–1.11) 0.002*
LVEF, % 0.97 (0.94–0.99) 0.004*    
A velocity, m/s 2.78 (0.71–10.8) 0.144*
E/e’ ratio 1.05 (1.01–1.09) 0.018* 1.08 (1.01–1.15) 0.026
Peak aortic jet velocity, per 0.5 m/s increase 1.57 (1.28–1.93) < 0.001* 1.79 (1.18–2.70) 0.006

A, late diastolic mitral inflow velocity; CRP, C-reactive protein; E/e′, Early diastolic velocity of the mitral annulus; LDL-C, low-density lipoprotein cholesterol; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; RVSP, right ventricular systolic pressure.

*

p value indicates the presence of statistical significance (p < 0.20).